Journal of Clinical Oncology (JCO) Podcast

The Journal of Clinical Oncology Podcast presents analyses and discussions centered on the latest findings published in ASCO's flagship Journal of Clinical Oncology. Host Dr. Davide Soldato facilitates interviews and scholarly discourse on the most impactful published findings. The Journal of Clinical Oncology Podcast is the trusted resource that empowers you to integrate cutting-edge evidence into clinical practice.The year's fellows interview authors and summarize the top Journal of Clinical Oncology articles in the series, JCO Article Insights.

Journal of Clinical Oncology (JCO) Podcast is a health podcast hosted by Unknown Host, with 465 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Unknown Host hosts Journal of Clinical Oncology (JCO) Podcast, a health show with 465 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Journal of Clinical Oncology (JCO) Podcast

  Bladder Adjuvant RadioTherapy (BART) RCT for High Risk MIBC

  Aug 13, 202618 min

  Guest Dr. Vedang Murthy and host Davide Soldato discuss JCO article, " Bladder Adjuvant Radiotherapy: Phase III Multicenter Randomized Controlled Trial of Adjuvant Radiotherapy or Observation for Postcystectomy Muscle-Invasive Bladder Cancer " and delve into trial design, results, clinical implications, and future directions in bladder cancer treatment. LINK TO FULL TRANSCRIPT

  ListenShow Notes
• 

  Journal of Clinical Oncology (JCO) Podcast

  JCO Article Insights: Duvelisib in Patients with Relapsed or Refractory PTCL

  Jul 27, 202611 min

  In this episode of JCO Article Insights, host Ash Gurumurthi summarizes the article " Duvelisib Induces Deep Responses in Peripheral T-Cell Lymphoma: Final Results of the Phase II PRIMO Trial of Duvelisib in Relapsed/Refractory Peripheral T-Cell Lymphoma ," by Mehta-Shah and colleagues. LINK TO FULL TRANSCRIPT

  ListenShow Notes
• 

  Journal of Clinical Oncology (JCO) Podcast

  Effectiveness of a Virtual Tobacco Treatment for Cancer Patients

  Jul 16, 202624 min

  Guests Dr. Elise Park, Dr. Jamie Ostrov and host Dr. Davide Soldato discuss JCO article " Virtual Sustained Tobacco Treatment for Cancer Patients: A Randomized Controlled Trial (ECOG-ACRIN: EAQ171CD) within the NCI Community Oncology Research Program (NCORP) " and their groundbreaking trial on virtual tobacco cessation treatment for cancer patients in community settings. LINK TO FULL TRANSCRIPT

  ListenShow Notes
• 

  Journal of Clinical Oncology (JCO) Podcast

  Phase 2 Study of Multi-Cancer Detection from Breath Samples

  Jun 11, 202620 min

  Guests Akash Kulgod and Dr. Sanjeev Kulgod and host Dr. Davide Soldato discuss JCO article, " Canine Olfaction Combined with Bayesian Modeling for Multi Cancer Detection from Breath Samples, a Phase 2 Study in India " and the innovative breath-based canine olfaction for multi-cancer detection in low-resource settings, the Bayesian modeling integration, and future prospects for scalable, non-invasive cancer screening methods. LINK TO FULL TRANSCRIPT

  ListenShow Notes
• 

  Journal of Clinical Oncology (JCO) Podcast

  JCO at ASCO 2026: Individualized Neoantigen Therapy Plus Pembrolizumab in Melanoma

  Jun 1, 202610 min

  JCO Editorial Fellow Dr. Ash Gurumurthi and JCO Associate Editor Dr. Grant McArthur discuss the ASCO 2026 Simultaneous Publication paper " Intismeran Autogene Plus Pembrolizumab Versus Pembrolizumab Alone in High-Risk Resected Melanoma: 5-Year Update of the Randomized Phase 2b KEYNOTE-942 Study ." LINK TO FULL TRANSCRIPT

  ListenShow Notes

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.